These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 10701146)
1. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Mahida YR Inflamm Bowel Dis; 2000 Feb; 6(1):21-33. PubMed ID: 10701146 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the mucosal immune system in inflammatory bowel disease. MacDermott RP J Gastroenterol; 1996 Dec; 31(6):907-16. PubMed ID: 9027661 [TBL] [Abstract][Full Text] [Related]
3. Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators. Lügering N; Kucharzik T; Stoll R; Domschke W Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):338-44. PubMed ID: 9759608 [TBL] [Abstract][Full Text] [Related]
4. [The cytokines in inflammatory bowel disease]. Polińska B; Matowicka-Karna J; Kemona H Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079 [TBL] [Abstract][Full Text] [Related]
5. New mediators of immunity and inflammation in inflammatory bowel disease. Monteleone G; Fina D; Caruso R; Pallone F Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of interleukin 17 in inflammatory bowel disease. Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762 [TBL] [Abstract][Full Text] [Related]
8. Chemokines in the inflammatory bowel diseases. MacDermott RP J Clin Immunol; 1999 Sep; 19(5):266-72. PubMed ID: 10535602 [TBL] [Abstract][Full Text] [Related]
9. [Cytokines in the pathogenesis of inflammatory bowel diseases]. José León A; Garrote JA; Arranz E Med Clin (Barc); 2006 Jun; 127(4):145-52. PubMed ID: 16831396 [TBL] [Abstract][Full Text] [Related]
10. The proportion of CD40+ mucosal macrophages is increased in inflammatory bowel disease whereas CD40 ligand (CD154)+ T cells are relatively decreased, suggesting differential modulation of these costimulatory molecules in human gut lamina propria. Carlsen HS; Yamanaka T; Scott H; Rugtveit J; Brandtzaeg P Inflamm Bowel Dis; 2006 Nov; 12(11):1013-24. PubMed ID: 17075342 [TBL] [Abstract][Full Text] [Related]